Clinical Trial Update: EDOCH Alternating With DHAP for New Diagnosed Younger MCL [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating EDOCH alternating with DHAP for newly diagnosed younger patients with Mantle Cell Lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• DHAP regimen
• EDOCH regimen

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Mantle Cell Lymphoma | Phase 4 | Status: COMPLETED